Photographer: Trevor Hagan/Bloomberg “DNA, of course I’m biased because it’s what I do, but it doesn’t lie. It really is a way to just sort of clear a lot of the b.s.,” said CJ Schwartz, chief executive officer of Sunrise Genetics, the Fort Collins, Colorado-based company behind the map. “The excessive claims are really doing a disservice to the plant or the potential of the plant and the science surrounding that.” A deeper understanding of genetics means companies will be able to figure out which parts of cannabis’s makeup drive different functions, making it easier to test for strain continuity and breed plants more quickly and effectively. Schwartz said the genome research can allow for more targeted recreational products by specifying exactly how a product might affect the body or mind, for instance by making a consumer feel tired or energized.   But knowledge of the full genome itself, which will be presented for the first time at the Plant and Animal Genome Conference in San Diego on January 17, also opens the door to the prospect of making good on some of the loftier possibilities for legal marijuana. A cannabis-based energy drink or sleepy-time tea could be on the horizon. Research aided by the genome map might identify potential cannabis-based medicine for further testing, bringing about a marijuana-derived painkiller or alternative to Viagra. What the Marijuana Genome Map Means for the Future of Pot

thumbnail courtesy of bloomberg.com